EUCTR2009-016762-87-IT进行中（未招募）不适用
a randomized, open-label study to evaluate the safety and efficacy of delayed introduction of sirolimus and concomitant tacrolimus elimination in de novo renal allograft recipients - early transition from tacrolimus to sirolimus
OSPEDALE MAGGIORE DI MILANO (IRCCS)0 个研究点开始时间: 2009年11月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •low immunological risk recipients of a de novo renal transplant
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •pregancy status, early acute rejection, infections, neoplasia,
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEARESTEUCTR2004-002629-36-SEWyeth Pharmaceuticals, Global Medical Affairs Department720
进行中（未招募）
不适用
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEARESTPsoriasis.EUCTR2004-002629-36-FIWyeth Pharmaceuticals, Global Medical Affairs Department720
进行中（未招募）
不适用
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with PsoriasisEUCTR2004-002629-36-BEWyeth Pharmaceuticals, Global Medical Affairs Department700
进行中（未招募）
1 期
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEARESTPsoriasis.EUCTR2004-002629-36-DKWyeth Pharmaceuticals, Global Medical Affairs Department720
进行中（未招募）
不适用
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with PsoriasispsoriasisEUCTR2004-002629-36-CZWyeth Pharmaceuticals, Global Medical Affairs Department700